Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception
Completed · Phase 2
Conditions studied: Healthy, Men, Male Contraception
In brief
The long term objective is to develop a gel to be used as a male contraceptive.
Key facts
- Study ID
- NCT03452111
- Run by
- Premier Research
- People needed
- 420
- Starts
- 2018-10-25
- Expected to finish
- 2024-09-06
- Last updated by the study team
- 2025-02-18
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.
Where it is running
- UC Davis Health — Sacramento, California, United States
- The Lunquist Institute at Harbor-UCLA Medical Center — Torrance, California, United States
- Comprehensive Women's Health Center — Denver, Colorado, United States
- University of Kansas — Kansas City, Kansas, United States
- Oregon Health & Science University — Portland, Oregon, United States
- University of Pennsylvania Medical Center — Philadelphia, Pennsylvania, United States
- University of Utah — Salt Lake City, Utah, United States
- Eastern Virginia Medical School-EVMS Obstetrics & Gynecology — Norfolk, Virginia, United States
- University of Washington Medical Center & Health Sciences — Seattle, Washington, United States
- Centro de Medicina Reproductiva Shady Grove Chile — Santiago, Vitacura, Chile
- Chilean Institute of Reproductive Medicine — Santiago, Chile
- University of Bologna, Italy — Bologna, Italy
- Kenyatta National Hospital — Nairobi, Kenya
- Karolinska Institutet — Stockholm, Sweden
- University of Edinburgh — Edinburgh, United Kingdom
- University of Manchester, UK — Manchester, United Kingdom
- Spilhaus Clinical Research Site — Harare, Zimbabwe
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.